Developer docs
API playgroundTry for free, no card

Search company profiles

Valid Insight

Full company profile

uuid000jpcf

Namestring
Valid Insight
Legal namestring
Valid Insight Limited
Company typeenum
Private
Founded yearint
2016
Descriptiontext

Valid Insight is a UK-based specialist market access consultancy serving life sciences companies across the full product lifecycle, from early development through post-launch optimization. The firm delivers project-based engagements spanning market access strategy, pricing, evidence synthesis, value communication, HTA submission preparation, and negotiation training, targeting pharmaceutical, biotech, MedTech, diagnostics, and medical nutrition clients. Over the past three years, Valid Insight has delivered projects in 40+ markets, supported 30+ clients including 6 of the top 10 biopharmaceutical companies, and maintained multi-year relationships with 10+ clients exceeding five years of continuous engagement.

The firm's core technology and proprietary assets center on the Pricing and Market Access Simulator (PMAS), which models payer willingness-to-pay dynamics, and an in-house payer and clinical opinion leader database covering more than 2,000 stakeholders. Its Integrated Dynamic Negotiation Training Model provides country-specific workshops, competitor war-gaming, and mock negotiations with local payer experts. Valid Insight has been a subsidiary of the Bioscript Group since 2021, enabling integrated delivery across regulatory, data insights, and medical communications disciplines. The firm has expanded its mix to include approximately 20% MedTech and Diagnostics projects and roughly 17% medical nutrition projects, alongside a pharmaceutical core focused on immunology, neurology, ophthalmology, oncology, and rare diseases.

Short descriptiontext

Valid Insight is a UK-based market access consultancy serving pharmaceutical, biotech, MedTech, and medical nutrition companies with pricing strategy, evidence synthesis, HTA support, and negotiation training across 40+ markets, operating as a subsidiary of the Bioscript Group since 2021.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersMacclesfield, United Kingdom
HQ citystring
Macclesfield
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
market access consulting, pharmaceutical consulting, health economics, value communication, payer engagement
Industry1 code
PRIMARYHLAGAOAN
Market Access, Pricing & Reimbursement (Evidence Generation) FSP
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)
NAICS code3 codes
  • Management, Scientific, and Technical Consulting Services5416
  • Management Consulting Services54161
  • Other Scientific and Technical Consulting Services54169
SIC code2 codes
  • Services-Management Consulting Services8742
  • Services-Engineering, Accounting, Research, Management8700
Product category
Pharmaceutical Market Access Consulting
Social media profiles2 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1Strategic Market Access Consulting
TypeProfessional Services
Description

Project-based consulting engagements across the product lifecycle, including market access strategy, pricing, evidence synthesis, value communication, and negotiation support. Engagements span early development through post-launch optimization.

validinsight.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Technology or R&D
Pricing details1 tier
1Custom project-based engagements
ModelOtherBilling cadenceMulti-year contract
Notes

Services quoted on a project-by-project basis depending on scope, complexity, therapeutic area, and geographic coverage requirements.

validinsight.com
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Valid Insight is a specialist market access consultancy that delivers strategic market access, pricing, evidence synthesis, value communication, and negotiation support services to life sciences companies across the product lifecycle — from early development through post-launch optimization. Services are delivered via project-based consulting engagements supported by proprietary tools including the Pricing and Market Access Simulator (PMAS) and an in-house database of 2,000+ payers and clinicians, with deep focus on pharmaceutical, biotech, MedTech, diagnostics, and medical nutrition clients.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Projects delivered in 40+ markets
+2 more records
Product overview1 text field

Valid Insight is a specialist market access consultancy that provides a suite of advisory services rather than a software platform. Their core offerings span the entire product lifecycle from early development through post-launch, including strategic market access consulting, value communication, payer research, pricing strategy, and evidence synthesis. Key proprietary offerings include the Pricing and Market Access Simulator (PMAS) for payer willingness-to-pay analysis, and an in-house database of over 2,000 payers and clinicians for primary research. The company specializes in pharmaceuticals (particularly immunology, neurology, ophthalmology, oncology, and rare disease), MedTech and diagnostics, medical nutrition, and environmental sustainability (ESG). Services include landscape assessments, HTA submissions, negotiation excellence training, tender strategy, value dossier development, and lifecycle management.

Product and service6 records
1Pricing and Market Access Simulator (PMAS)
CategoryDecision-support tool / proprietary methodology
Description

A proprietary simulator that models payer willingness-to-pay dynamics, providing insight into pricing thresholds and market access scenarios. Used to empower life sciences companies with informed access and pricing strategies.

2Strategic Market Access Consulting
CategoryConsulting service
Description

End-to-end market access advisory covering opportunity evaluation, value substantiation, stakeholder communication, access strategy fine-tuning, launch readiness, and post-launch lifecycle management for life sciences clients.

3Evidence Synthesis and Value Communication
CategoryConsulting service
Description

Development of evidence-based value narratives, value dossiers, manuscripts, objection handlers, and economic models designed for HTA bodies, payers, and clinicians in pharmaceutical, MedTech, and medical nutrition contexts.

4Negotiation Training and Excellence Workshops
CategoryConsulting service / Training
Description

Country-specific facilitated workshops equipping affiliate teams with negotiation skills, competitor war-gaming, and mock negotiations led by local payer experts, often delivered across multiple affiliate markets.

5Primary Payer and Clinician Research
CategoryConsulting service / Primary research
Description

Primary market research with payers, hospital pharmacists, and clinical opinion leaders to surface insights on pricing, positioning, evidence requirements, and stakeholder engagement strategies.

6HTA and Reimbursement Submission Support
CategoryConsulting service
Description

Preparation of HTA submissions, reimbursement dossiers, objection handlers, and tender management support for submissions to bodies such as NICE, HAS, G-BA, and WHO.

Scale indicator13 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2021-01-01
Description

Valid Insight joined the Bioscript Group in 2021, gaining access to a network of experts in data insights, regulatory, and medical communications. This enables integrated project delivery with smooth knowledge transfer and cohesive strategy across market access, regulatory, and medical initiatives.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2019-01-01
Description

Partnered in 2019 to host a roundtable at BIO-Europe focusing on best practices in payer engagement, gathering senior leaders from pharmaceutical and healthcare industries. Results published as whitepaper in early 2020.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Internal partnership within Bioscript Group combining payer-first thinking with data-driven analytics from the BDI team to help clients set products on optimal market access trajectories.

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

PRMA Consulting is a specialist market access consultancy serving biopharmaceutical clients with pricing, reimbursement, and evidence synthesis services across global markets. It is the closest direct competitor to Valid Insight in size, scope, and therapeutic-area breadth.

TypeDirect peer
Description

Mtech Access is a UK-based boutique market access consultancy offering strategic pricing, reimbursement, and HTA submission support to life sciences companies. Its service portfolio and target client base overlap almost entirely with Valid Insight's core offering.

TypeDirect peer
Description

Avalere Health is a US-headquartered healthcare consultancy with deep market access, HTA, and value-communication practices serving biopharma and MedTech. It competes with Valid Insight on global payer evidence and pricing strategy mandates.

TypeBroad incumbent
Description

Evidera, part of Thermo Fisher's PPD clinical research business, provides evidence synthesis, HTA, and market access services alongside broader CRO capabilities. It is a larger, more diversified incumbent competing for the same payer evidence and value communication work.

TypeBroad incumbent
Description

CRA's Life Sciences practice offers pricing, market access, and commercial strategy consulting to global biopharma. As a broader consulting firm, it overlaps with Valid Insight on strategic pricing and access engagements but at greater scale and with different delivery economics.

TypeBroad incumbent
Description

Syneos Health Consulting provides market access, pricing, and value strategy services integrated with its clinical and commercial CRO offerings. It competes with Valid Insight on biopharma access mandates, particularly those requiring global, multi-workstream delivery.

TypeDirect peer
Description

Putnam Associates is a strategy consultancy focused on biopharma pricing, market access, and launch strategy. Its boutique positioning and therapeutic-area depth make it a direct peer for Valid Insight's pricing and access strategy work.

TypeBroad incumbent
Description

IQVIA operates one of the largest market access and pricing practices globally, combining proprietary data assets with consulting delivery. It is the dominant incumbent against which Valid Insight competes for large, multi-region biopharma mandates.

9MAP BioPharma
TypeDirect peer
Description

MAP BioPharma is a UK-based market access consultancy offering pricing, reimbursement, and HTA support to pharma and MedTech clients. Its service offering, geography, and client mix closely mirror Valid Insight's niche positioning.

TypeDirect peer
Description

Validant is a regulatory and market access consultancy serving life sciences companies with pricing, reimbursement, and launch readiness services. Its focus and service portfolio overlap directly with Valid Insight's strategic access engagements.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers8 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Valid Insight

Pharmaceutical Market Access Consultingvalidinsight.com

Valid Insight is a UK-based market access consultancy serving pharmaceutical, biotech, MedTech, and medical nutrition companies with pricing strategy, evidence synthesis, HTA support, and negotiation training across 40+ markets, operating as a subsidiary of the Bioscript Group since 2021.

What Valid Insight does

Valid Insight is a UK-based specialist market access consultancy serving life sciences companies across the full product lifecycle, from early development through post-launch optimization. The firm delivers project-based engagements spanning market access strategy, pricing, evidence synthesis, value communication, HTA submission preparation, and negotiation training, targeting pharmaceutical, biotech, MedTech, diagnostics, and medical nutrition clients. Over the past three years, Valid Insight has delivered projects in 40+ markets, supported 30+ clients including 6 of the top 10 biopharmaceutical companies, and maintained multi-year relationships with 10+ clients exceeding five years of continuous engagement.

The firm's core technology and proprietary assets center on the Pricing and Market Access Simulator (PMAS), which models payer willingness-to-pay dynamics, and an in-house payer and clinical opinion leader database covering more than 2,000 stakeholders. Its Integrated Dynamic Negotiation Training Model provides country-specific workshops, competitor war-gaming, and mock negotiations with local payer experts. Valid Insight has been a subsidiary of the Bioscript Group since 2021, enabling integrated delivery across regulatory, data insights, and medical communications disciplines. The firm has expanded its mix to include approximately 20% MedTech and Diagnostics projects and roughly 17% medical nutrition projects, alongside a pharmaceutical core focused on immunology, neurology, ophthalmology, oncology, and rare diseases.

Valid Insight firmographics

Firmographics
Name
Valid Insight
Legal name
Valid Insight Limited
Website
https://validinsight.com
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
11–50 employees
Short description
Valid Insight is a UK-based market access consultancy serving pharmaceutical, biotech, MedTech, and medical nutrition companies with pricing strategy, evidence synthesis, HTA support, and negotiation training across 40+ markets, operating as a subsidiary of the Bioscript Group since 2021.
Ownership category
akta.pro rank

Valid Insight industry classification

Industry
Product category
Pharmaceutical Market Access Consulting
NAICS
Management, Scientific, and Technical Consulting Services (5416), Management Consulting Services (54161), Other Scientific and Technical Consulting Services (54169)
SIC
Services-Management Consulting Services (8742), Services-Engineering, Accounting, Research, Management (8700)
akta.pro industry
PRIMARYHLAGAOAN
Market Access, Pricing & Reimbursement (Evidence Generation) FSP
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)

Keywords

  • Market access consulting
  • Pharmaceutical consulting
  • Health economics
  • Value communication
  • Payer engagement

Where Valid Insight is headquartered

Location

Headquarters

HQ city
Macclesfield
HQ country
United Kingdom
HQ region
Europe

Offices2 records

Markets served

Valid Insight business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

  1. Strategic Market Access Consulting: Project-based consulting engagements across the product lifecycle, including market access strategy, pricing, evidence synthesis, value communication, and negotiation support. Engagements span early development through post-launch optimization.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractCustom project-based engagements

Go-to-market motion2 records

Distribution channels2 records

Marketing channels6 records

Valid Insight product offering

Product offering

Core offering

Valid Insight is a specialist market access consultancy that delivers strategic market access, pricing, evidence synthesis, value communication, and negotiation support services to life sciences companies across the product lifecycle — from early development through post-launch optimization. Services are delivered via project-based consulting engagements supported by proprietary tools including the Pricing and Market Access Simulator (PMAS) and an in-house database of 2,000+ payers and clinicians, with deep focus on pharmaceutical, biotech, MedTech, diagnostics, and medical nutrition clients.

Product overview

Valid Insight is a specialist market access consultancy that provides a suite of advisory services rather than a software platform. Their core offerings span the entire product lifecycle from early development through post-launch, including strategic market access consulting, value communication, payer research, pricing strategy, and evidence synthesis. Key proprietary offerings include the Pricing and Market Access Simulator (PMAS) for payer willingness-to-pay analysis, and an in-house database of over 2,000 payers and clinicians for primary research. The company specializes in pharmaceuticals (particularly immunology, neurology, ophthalmology, oncology, and rare disease), MedTech and diagnostics, medical nutrition, and environmental sustainability (ESG). Services include landscape assessments, HTA submissions, negotiation excellence training, tender strategy, value dossier development, and lifecycle management.

Differentiator

Problem solved

Functional benefit

Products and services

  • Pricing and Market Access Simulator (PMAS) A proprietary simulator that models payer willingness-to-pay dynamics, providing insight into pricing thresholds and market access scenarios. Used to empower life sciences companies with informed access and pricing strategies.
  • Strategic Market Access Consulting End-to-end market access advisory covering opportunity evaluation, value substantiation, stakeholder communication, access strategy fine-tuning, launch readiness, and post-launch lifecycle management for life sciences clients.
  • Evidence Synthesis and Value Communication Development of evidence-based value narratives, value dossiers, manuscripts, objection handlers, and economic models designed for HTA bodies, payers, and clinicians in pharmaceutical, MedTech, and medical nutrition contexts.
  • Negotiation Training and Excellence Workshops Country-specific facilitated workshops equipping affiliate teams with negotiation skills, competitor war-gaming, and mock negotiations led by local payer experts, often delivered across multiple affiliate markets.
  • Primary Payer and Clinician Research Primary market research with payers, hospital pharmacists, and clinical opinion leaders to surface insights on pricing, positioning, evidence requirements, and stakeholder engagement strategies.
  • HTA and Reimbursement Submission Support Preparation of HTA submissions, reimbursement dossiers, objection handlers, and tender management support for submissions to bodies such as NICE, HAS, G-BA, and WHO.

Quantifiable outcome

  • Projects delivered in 40+ markets
  • +2 more outcomes

Companies that use Valid Insight

Customer profile

Named customers8 records

Segments4 records

Ideal customer profiles3 records

Valid Insight technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Valid Insight partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core and minor.

  • Bioscript GroupcoreStrategic or Co-development Partner · 1 January 2021Valid Insight joined the Bioscript Group in 2021, gaining access to a network of experts in data insights, regulatory, and medical communications. This enables integrated project delivery with smooth knowledge transfer and cohesive strategy across market access, regulatory, and medical initiatives.
  • Informa Pharma IntelligenceminorStrategic or Co-development Partner · 1 January 2019Partnered in 2019 to host a roundtable at BIO-Europe focusing on best practices in payer engagement, gathering senior leaders from pharmaceutical and healthcare industries. Results published as whitepaper in early 2020.
  • Bioscript Data Insights (BDI) TeamcoreStrategic or Co-development PartnerInternal partnership within Bioscript Group combining payer-first thinking with data-driven analytics from the BDI team to help clients set products on optimal market access trajectories.

Scale indicators13 records

Recent moves4 records

Expansion highlights5 records

Valid Insight competitors and assessment

Company assessment

Direct peers

  • PRMA Consulting: PRMA Consulting is a specialist market access consultancy serving biopharmaceutical clients with pricing, reimbursement, and evidence synthesis services across global markets. It is the closest direct competitor to Valid Insight in size, scope, and therapeutic-area breadth.
  • Mtech Access: Mtech Access is a UK-based boutique market access consultancy offering strategic pricing, reimbursement, and HTA submission support to life sciences companies. Its service portfolio and target client base overlap almost entirely with Valid Insight's core offering.
  • Avalere Health: Avalere Health is a US-headquartered healthcare consultancy with deep market access, HTA, and value-communication practices serving biopharma and MedTech. It competes with Valid Insight on global payer evidence and pricing strategy mandates.
  • Putnam Associates: Putnam Associates is a strategy consultancy focused on biopharma pricing, market access, and launch strategy. Its boutique positioning and therapeutic-area depth make it a direct peer for Valid Insight's pricing and access strategy work.
  • MAP BioPharma: MAP BioPharma is a UK-based market access consultancy offering pricing, reimbursement, and HTA support to pharma and MedTech clients. Its service offering, geography, and client mix closely mirror Valid Insight's niche positioning.
  • Validant: Validant is a regulatory and market access consultancy serving life sciences companies with pricing, reimbursement, and launch readiness services. Its focus and service portfolio overlap directly with Valid Insight's strategic access engagements.

Broad incumbents

  • Evidera (PPD / Thermo Fisher): Evidera, part of Thermo Fisher's PPD clinical research business, provides evidence synthesis, HTA, and market access services alongside broader CRO capabilities. It is a larger, more diversified incumbent competing for the same payer evidence and value communication work.
  • Charles River Associates (Life Sciences): CRA's Life Sciences practice offers pricing, market access, and commercial strategy consulting to global biopharma. As a broader consulting firm, it overlaps with Valid Insight on strategic pricing and access engagements but at greater scale and with different delivery economics.
  • Syneos Health Consulting: Syneos Health Consulting provides market access, pricing, and value strategy services integrated with its clinical and commercial CRO offerings. It competes with Valid Insight on biopharma access mandates, particularly those requiring global, multi-workstream delivery.
  • IQVIA (Real World Evidence / Market Access): IQVIA operates one of the largest market access and pricing practices globally, combining proprietary data assets with consulting delivery. It is the dominant incumbent against which Valid Insight competes for large, multi-region biopharma mandates.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

Valid Insight social profiles

Digital presence

Valid Insight financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Valid Insight leadership team

Management profile

Number of profiles

Profiles6 records

Valid Insight funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Valid Insight M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Valid Insight

What does Valid Insight do?

Valid Insight is a specialist market access consultancy that delivers strategic market access, pricing, evidence synthesis, value communication, and negotiation support services to life sciences companies across the product lifecycle — from early development through post-launch optimization. Services are delivered via project-based consulting engagements supported by proprietary tools including the Pricing and Market Access Simulator (PMAS) and an in-house database of 2,000+ payers and clinicians, with deep focus on pharmaceutical, biotech, MedTech, diagnostics, and medical nutrition clients.

Is Valid Insight a public or private company?

Valid Insight is a private company. It is classified as corporate owned and is currently operating.

When was Valid Insight founded?

Valid Insight was founded in 2016. It employs 11 to 50 people.

Where is Valid Insight based?

Valid Insight is headquartered in Macclesfield, United Kingdom, in the Europe region.

How does Valid Insight make money?

One revenue line is on record: strategic Market Access Consulting.

Who are Valid Insight's main competitors?

Direct peers on record are PRMA Consulting, Mtech Access, Avalere Health, Putnam Associates, MAP BioPharma and Validant. Broad incumbents are Evidera (PPD / Thermo Fisher), Charles River Associates (Life Sciences), Syneos Health Consulting and IQVIA (Real World Evidence / Market Access).

Does Valid Insight have an API?

No public API is recorded for Valid Insight.

What industry is Valid Insight in?

Valid Insight's product category is Pharmaceutical Market Access Consulting. Its primary akta.pro industry code is HLAGAOAN, Market Access, Pricing & Reimbursement (Evidence Generation) FSP. Its NAICS code is 5416 and its SIC code is 8742.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals